These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 12560438)

  • 21. Carbonic anhydrase IX expression in prostate cancer.
    Smyth LG; O'Hurley G; O'Grady A; Fitzpatrick JM; Kay E; Watson RW
    Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):178-81. PubMed ID: 20038959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
    Koukourakis MI; Giatromanolaki A; Brekken RA; Sivridis E; Gatter KC; Harris AL; Sage EH
    Cancer Res; 2003 Sep; 63(17):5376-80. PubMed ID: 14500371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of CA-IX is associated with advanced stage tumors and poor survival in oral squamous cell carcinoma patients.
    Pérez-Sayáns M; Suárez-Peñaranda JM; Pilar GD; Supuran CT; Pastorekova S; Barros-Angueira F; Gándara-Rey JM; García-García A
    J Oral Pathol Med; 2012 Oct; 41(9):667-74. PubMed ID: 22486898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.
    Zerati M; Leite KR; Pontes-Junior J; Segre CC; Reis ST; Srougi M; Dall'Oglio MF
    Int Braz J Urol; 2013; 39(4):484-92. PubMed ID: 24054396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.
    Chia SK; Wykoff CC; Watson PH; Han C; Leek RD; Pastorek J; Gatter KC; Ratcliffe P; Harris AL
    J Clin Oncol; 2001 Aug; 19(16):3660-8. PubMed ID: 11504747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas.
    Hedley D; Pintilie M; Woo J; Morrison A; Birle D; Fyles A; Milosevic M; Hill R
    Clin Cancer Res; 2003 Nov; 9(15):5666-74. PubMed ID: 14654550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer.
    Mees G; Vangestel C; Dierckx R; Pauwels P; Van Meerbeeck J; Van de Wiele C
    Cancer Biother Radiopharm; 2010 Apr; 25(2):149-54. PubMed ID: 20423227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of new prognostic markers, peripheral-type benzodiazepine receptor and carbonic anhydrase IX, in human breast and ovarian carcinoma cell lines.
    Hunakova L; Bodo J; Chovancova J; Sulikova G; Pastorekova S; Sedlak J
    Neoplasma; 2007; 54(6):541-8. PubMed ID: 17949239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment.
    Ibis K; Saglam S; Saglam EK; Firat P; Yilmazbayhan D; Toker A; Ozkan B; Hancer VS; Buyukdogan M; Disci R; Pilanci KN
    Pathol Res Pract; 2018 Sep; 214(9):1291-1296. PubMed ID: 30029935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxic tumor microenvironment in advanced retinoblastoma.
    Sudhakar J; Venkatesan N; Lakshmanan S; Khetan V; Krishnakumar S; Biswas J
    Pediatr Blood Cancer; 2013 Oct; 60(10):1598-601. PubMed ID: 23804414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix.
    Loncaster JA; Harris AL; Davidson SE; Logue JP; Hunter RD; Wycoff CC; Pastorek J; Ratcliffe PJ; Stratford IJ; West CM
    Cancer Res; 2001 Sep; 61(17):6394-9. PubMed ID: 11522632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of carbonic anhydrase IX expression by cancer-associated fibroblasts in lung adenocarcinoma.
    Nakao M; Ishii G; Nagai K; Kawase A; Kenmotsu H; Kon-No H; Hishida T; Nishimura M; Yoshida J; Ochiai A
    Cancer; 2009 Jun; 115(12):2732-43. PubMed ID: 19365853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer.
    Chu CY; Jin YT; Zhang W; Yu J; Yang HP; Wang HY; Zhang ZJ; Liu XP; Zou Q
    Int J Oncol; 2016 Jan; 48(1):271-80. PubMed ID: 26648580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
    Andersen S; Eilertsen M; Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
    Lung Cancer; 2011 Jun; 72(3):294-302. PubMed ID: 21075472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of CAIX and CAXII to in vitro re-oxygenation and clinical significance of the combined expression in NSCLC patients.
    Ilie M; Hofman V; Zangari J; Chiche J; Mouroux J; Mazure NM; Pouysségur J; Brest P; Hofman P
    Lung Cancer; 2013 Oct; 82(1):16-23. PubMed ID: 23910904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer.
    Ambrosio MR; Di Serio C; Danza G; Rocca BJ; Ginori A; Prudovsky I; Marchionni N; Del Vecchio MT; Tarantini F
    Diagn Pathol; 2016 May; 11(1):45. PubMed ID: 27225200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor.
    Ostheimer C; Bache M; Güttler A; Kotzsch M; Vordermark D
    Strahlenther Onkol; 2014 Mar; 190(3):276-82. PubMed ID: 24322994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase IX, a marker of hypoxia: correlation with clinical outcome in transitional cell carcinoma of the bladder.
    Hussain SA; Palmer DH; Ganesan R; Hiller L; Gregory J; Murray PG; Pastorek J; Young L; James ND
    Oncol Rep; 2004 May; 11(5):1005-10. PubMed ID: 15069539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma.
    Vermylen P; Roufosse C; Burny A; Verhest A; Bosschaerts T; Pastorekova S; Ninane V; Sculier JP
    Eur Respir J; 1999 Oct; 14(4):806-11. PubMed ID: 10573225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Necrosis and hypoxia in invasive breast carcinoma.
    Tomes L; Emberley E; Niu Y; Troup S; Pastorek J; Strange K; Harris A; Watson PH
    Breast Cancer Res Treat; 2003 Sep; 81(1):61-9. PubMed ID: 14531498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.